Tagged with MP

Hungary Katinka Zinnemers, managing director of Abacus Medicine, highlights the company’s mission to increase access to medicines for all patients and its commitment to building trust with authorities as it enters into the arena of parallel imports.     As a parallel trade company, we must be compliant in the same manner…

Puerto Rico When life sciences companies decide to transfer the production of new drug to Puerto Rico, extend an existing production line, or simply sustain existing operations, they can count on the support of a vast network of service providers with unmatched expertise in quality and regulatory compliance, from premarket approval (PMA)…

Puerto Rico Celebrating its 45th anniversary in Puerto Rico this year, Medtronic is the largest life sciences company on the island with four manufacturing locations in Juncos, Villalba, Ponce and Humacao, as well as commercial operations. Its manufacturing footprint covers 900,000 sq. feet and employs more than 5,000 employees in total, making…

China Within the industry, Allergan already stands out for the interesting composition of its portfolio. For China President White Wang, this was precisely the attraction. He enthuses, “Allergan is truly a very unique company. It is at once a pharma company, a medical device company, a cosmetics/aesthetics company and a digital…

Korea Multinational pharma company managers working abroad must adapt to new cultures and develop a deep understanding of local markets. Korea is no different; here three foreign country managers give their first impressions and insights into the Korean pharma market.   Nic Horridge, Roche   As a newcomer in the land…

Hungary István Peták, co-founder and CEO of Oncompass introduces the innovative start-up and elaborates on how its solution for digital treatment planning and digital biomarkers can revolutionize not only personalized oncology treatment for patients, but also be a key tool in accelerating the clinical development of new targeted therapies.   The…

UAE The UAE pharma market is projected to grow over 80 percent by 2027, in part due to a growing demand for the treatment of lifestyle diseases and expansion of comprehensive health insurance.  Made with Visme Presentation Maker     Pharmaceutical imports into the UAE come from 72 countries. 80 percent…

Hungary The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the government of  Prime Minister Viktor Orbán. Here, we highlight four Hungarian pharma champions and their evolving strategies.   Beres Béres Pharmaceuticals was conceived from…

Turkey There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has the private hospital group revolutionized healthcare in Turkey with its advanced facilities, but it has also pursued an ambitious internationalization campaign and even opened a world-class university, to boot.   We…

Hong Kong Dr Joseph Tam is indisputably one of the pioneers of Hong Kong’s biotech industry, having returned to Hong Kong in 1973 following an illustrious career in the US to bring in novel technologies to the city.   I feel happy that I have achieved my initial objectives: to bring international…

Sweden In a market where revolutionary treatments and new technologies threaten to introduce structural changes, the need for national authorities and regulators to adapt and catch up with the pace of the industry is of uttermost importance. Dr Catarina Andersson Forsman, director general of the Swedish Medical Products Agency (MPA), shares…

China 2009 marks 40 years of China’s liberalization and opening up under then-Premier Deng Xiaoping. Servier China also bears the distinction of having been established that year, celebrating its 40th anniversary in tandem with its host country.   The success of Servier China is based on the quality of the people…